⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
QNTM
Grant & Eisenhofer Files Securities Class Action Lawsuit Against Canadian Imperial Bank of Commerce and Royal Bank of Canada on behalf of investors in Quantum Biopharma Ltd. Securities
businesswire.com
QNTM
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
accessnewswire.com
QNTM
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
globenewswire.com
QNTM
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
globenewswire.com
QNTM
Innovative Technology Company, QNTUM, Brings High Powered Sales and Astonishing Customer Service to the Roofing Industry
businesswire.com
QNTM
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
newsfilecorp.com
QNTM
Quantum Cryptography Market worth $10.2 billion by 2031 | MarketsandMarkets™
prnewswire.com
DGII
MAGIQ
QBTS
QNTM
FTNT
IBM
HPE
RAMB
QYLD
QUCH
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
globenewswire.com
QNTM
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
globenewswire.com
QNTM